Grant: Planning and Dissemination Grant - Institute Community Support
University of British Columbia
$10,000.00
Planning and development of a Sexually Transmitted Infections Vaccine Consortium in British Columbia (STRIVE-BC)
FY 2017-18
Summary
Annually over half a billion sexually transmitted infections (STI) occur worldwide. STIs are a significant cause of illness, death and health system burden globally and can lead to fetal & neonatal death, various types of cancer, infertility, increased HIV risk, and physical and psychosocial distress. In Canada, rates of STIs including chlamydia, gonorrhea, and syphilis have been steadily increasing in recent decades. Currently, vaccine preventable STIs include HPV and Hepatitis B; however, vaccines are currently in development for other STIs as well. In June 2016, the World Health Organization (WHO) highlighted STIs as a priority focus, with ambitious targets set for 2030 with regard to significant reductions of STI in 80% of countries globally. While the science of STI vaccines continues to advance, there are important factors that research and policy groups need to consider to ensure quality, uptake and equity in vaccination programs. British Columbia (BC) is an established global leader in HPV vaccine policy planning, priority setting, research, and evaluation. We have the opportunity to leverage the BC experience with HPV vaccine development, program implementation, and evaluation and extend it to other STI vaccines. The objective of this project will be to establish a BC based STI vaccine consortium (STRIVE-BC), comprised primarily of UBC researchers and collaborators with expertise in STI and vaccine research, policy and implementation. Planned activities include assembling a diverse team of leading academic and public health leaders to identify emerging issues, to explore gaps and opportunities, and to conduct an environmental scan on STI vaccines. In addition, preparation for a full day workshop to be held at an international meeting, attended by global leaders will be a priority.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
383729
Name
Ogilvie Gina S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Health systems / services
Prcname2
Planning and Dissemination - III
Projecttitle
Planning and development of a Sexually Transmitted Infections Vaccine Consortium in British Columbia (STRIVE-BC)
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Vaccines Development
Abstract
Annually over half a billion sexually transmitted infections (STI) occur worldwide. STIs are a significant cause of illness, death and health system burden globally and can lead to fetal & neonatal death, various types of cancer, infertility, increased HIV risk, and physical and psychosocial distress. In Canada, rates of STIs including chlamydia, gonorrhea, and syphilis have been steadily increasing in recent decades. Currently, vaccine preventable STIs include HPV and Hepatitis B; however, vaccines are currently in development for other STIs as well. In June 2016, the World Health Organization (WHO) highlighted STIs as a priority focus, with ambitious targets set for 2030 with regard to significant reductions of STI in 80% of countries globally. While the science of STI vaccines continues to advance, there are important factors that research and policy groups need to consider to ensure quality, uptake and equity in vaccination programs. British Columbia (BC) is an established global leader in HPV vaccine policy planning, priority setting, research, and evaluation. We have the opportunity to leverage the BC experience with HPV vaccine development, program implementation, and evaluation and extend it to other STI vaccines. The objective of this project will be to establish a BC based STI vaccine consortium (STRIVE-BC), comprised primarily of UBC researchers and collaborators with expertise in STI and vaccine research, policy and implementation. Planned activities include assembling a diverse team of leading academic and public health leaders to identify emerging issues, to explore gaps and opportunities, and to conduct an environmental scan on STI vaccines. In addition, preparation for a full day workshop to be held at an international meeting, attended by global leaders will be a priority.
Competitiondate
201803
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ogilvie, Gina S
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $10,000~ $0~